marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Pulse Biosciences Balance Sheet 2011-2024 | PLSE
Annual Balance Sheet Pulse Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-35.2 M | -51.1 M | -17.8 M | - | -180 K | -51.1 M | -3.39 M | -2.09 M | -3.61 M | -7.01 M | - | - | - |
Long Term Debt |
8.09 M | 9.14 M | 10 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.06 M | 896 K | 774 K | 542 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 6.72 M | 1.2 M | 1.61 M | - | - | 1.66 M | - | - | - |
Total Current Liabilities |
6.71 M | 5.98 M | 8.52 M | 7.58 M | 4.46 M | 3.11 M | 2.21 M | 1.02 M | - | - | - | - | - |
Total Liabilities |
14.8 M | 80.1 M | 18.6 M | 18.4 M | 11.2 M | 4.31 M | 3.83 M | 1.02 M | 660 K | 1.82 M | - | - | - |
Deferred Revenue |
- | - | 16 K | - | - | - | - | - | - | 39.5 K | - | - | - |
Retained Earnings |
-337 M | -295 M | -236 M | -173 M | -123 M | -75.7 M | -38.2 M | -12.6 M | -3.09 M | -277 K | - | - | - |
Total Assets |
59.2 M | 77.9 M | 54.2 M | 41.3 M | 41.9 M | 70.6 M | 49.8 M | 26.3 M | 14.3 M | 17.9 M | - | - | - |
Cash and Cash Equivalents |
44.4 M | 61.1 M | 28.6 M | 12.5 M | 6.9 M | 51.1 M | 3.39 M | 2.09 M | 3.61 M | 7.01 M | - | - | - |
Book Value |
44.4 M | -2.25 M | 35.7 M | 22.9 M | 30.7 M | 66.3 M | 46 M | 25.3 M | 13.7 M | 16.1 M | - | - | - |
Total Shareholders Equity |
44.4 M | -2.25 M | 35.7 M | 22.9 M | 30.7 M | 66.3 M | 46 M | 25.3 M | 13.7 M | 16.1 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Pulse Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
7.17 M | 7.5 M | 7.8 M | 8.09 M | 8.37 M | 8.64 M | 8.9 M | 9.14 M | 9.38 M | 9.62 M | 9.83 M | 8.09 M | 10.2 M | 10.4 M | 10.6 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 6.72 M | 6.72 M | 6.72 M | 6.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
13.9 M | 13.5 M | 12.9 M | 14.8 M | 13.8 M | 14.3 M | 80.9 M | 80.1 M | 81.4 M | 17.2 M | 18.7 M | 14.8 M | 19.8 M | 20.3 M | 60.2 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 4.31 M | 4.31 M | 4.31 M | 4.31 M | 3.83 M | 3.83 M | 3.83 M | 3.83 M | 1.02 M | 1.02 M | 1.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | 4 K | - | 38 K | 32 K | 16 K | 16 K | 7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-371 M | -358 M | -347 M | -337 M | -325 M | -314 M | -305 M | -295 M | -286 M | -267 M | -253 M | -337 M | -221 M | -207 M | -191 M | -173 M | -173 M | -173 M | -173 M | -123 M | -123 M | -123 M | -123 M | -75.7 M | -75.7 M | -75.7 M | -75.7 M | -38.2 M | -38.2 M | -38.2 M | -38.2 M | -12.6 M | -12.6 M | -12.6 M | -12.6 M | -3.09 M | -3.09 M | -3.09 M | -3.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
93 M | 40.4 M | 49.2 M | 59.2 M | 65.9 M | 74.8 M | 70.2 M | 77.9 M | 87.6 M | 40.6 M | 39.5 M | 59.2 M | 67.1 M | 80 M | 80.6 M | 41.3 M | 41.3 M | 41.3 M | 41.3 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 70.6 M | 70.6 M | 70.6 M | 70.6 M | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
79 M | 26.2 M | 34.9 M | 44.4 M | 50.4 M | 58.7 M | 54.1 M | 61.1 M | 69.2 M | 14.8 M | 12.7 M | 44.4 M | 42 M | 47.4 M | 59.9 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 51.1 M | 51.1 M | 51.1 M | 51.1 M | 3.39 M | 3.39 M | 3.39 M | 3.39 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 7.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
79.1 M | 27 M | 36.3 M | 44.4 M | 52.1 M | 60.5 M | -10.7 M | -2.25 M | 6.19 M | 23.4 M | 20.8 M | 44.4 M | 47.4 M | 59.8 M | 20.4 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 46 M | 46 M | 46 M | 46 M | 25.3 M | 25.3 M | 25.3 M | 26.3 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
79.1 M | 27 M | 36.3 M | 44.4 M | 52.1 M | 60.5 M | -10.7 M | -2.25 M | 6.19 M | 23.4 M | 20.8 M | 44.4 M | 47.4 M | 59.8 M | 20.4 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 46 M | 46 M | 46 M | 46 M | 25.3 M | 25.3 M | 25.3 M | 25.3 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency